Subscribe To
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of revance therapeutics, inc. – rvnc
NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ...
September 25, 2023, 8:34 pm
revance therapeutics: impressive sales growth/concerning cash burn
revance Therapeutics, Inc. stock has fallen by half in the past six months, despite impressive sales gr...
September 15, 2023, 5:51 pm
Cerevance announces presentation at the 22nd society of chemical industry / royal society of chemistry medicinal chemistry symposium
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and deve...
August 31, 2023, 12:30 pm
revance shares gain 8% after fda approval of cervical dystonia treatment
Shares of revance Therapeutics Inc. RVNC, -3.81% gained 8% premarket on Monday after the U.S. Food and ...
August 14, 2023, 8:53 am
revance's botox rival gets fda approval for painful neck muscle condition
The U.S. health regulator has approved expanding the use of revance Therapeutics' Daxxify to treat a pa...
August 14, 2023, 8:06 am
revance therapeutics, inc. (rvnc) reports q2 loss, tops revenue estimates
revance Therapeutics, Inc. (RVNC) came out with a quarterly loss of $0.80 per share versus the Zacks Co...
August 8, 2023, 7:41 pm
After plunging -17.93% in 4 weeks, here's why the trend might reverse for revance therapeutics, inc. (rvnc)
revance Therapeutics, Inc. (RVNC) has become technically an oversold stock now, which implies exhaustio...
July 13, 2023, 11:08 am
Evolus: botox copy cat in a challenging aesthetic market
Evolus, Inc., a pharmaceutical company specializing in aesthetic products, faces significant challenges with its lead product Jeuveau, a treatment for...
June 29, 2023, 2:51 pm
This botox rival has investors smiling with a 100% gain this year. the stock broke out today.
revance Therapeutics, a biotech stock, is at a 52-week high and reports earnings Tuesday. Their frown l...
May 9, 2023, 2:16 pm
revance therapeutics: rally seems due for a pause
Today, we take a deeper look at revance Therapeutics, Inc., a developer of aesthetic products that is s...
April 3, 2023, 7:57 pm
Wall street sees 23% upside in revance, maker of botox competitor
Investors in revance Therapeutics Inc. (NASDAQ: RVNC) shouldn't have much to frown about after the stoc...
March 2, 2023, 7:21 am
revance therapeutics, inc. (rvnc) q4 2022 earnings call transcript
revance Therapeutics, Inc. (NASDAQ:RVNC ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 AM ET...
February 28, 2023, 11:26 pm
revance therapeutics, inc. (rvnc) reports q4 loss, tops revenue estimates
revance Therapeutics, Inc. (RVNC) delivered earnings and revenue surprises of -75% and 6.62%, respectiv...
February 28, 2023, 9:05 pm
Daxxify™ is now available at rockland’s skin klinic & day spa
The Aesthetic-Focused Team Began Offering a New, Longer-Lasting Wrinkle Relaxer Starting December 2022 ROCKLAND, Maine, Feb. 08, 2023 (GLOBE NEWSWIRE)...
February 8, 2023, 10:12 pm
What makes revance therapeutics, inc. (rvnc) a strong momentum stock: buy now?
Does revance Therapeutics, Inc. (RVNC) have what it takes to be a top stock pick for momentum investors...
February 2, 2023, 1:33 pm
Jpmorgan chase cuts stake in revance therapeutics
Fintel reports that Jpmorgan Chase & Co has filed a 13G/A form with the SEC disclosing ownership of 4.98MM shares of ...
January 30, 2023, 10:38 pm
revance therapeutics, inc. (rvnc) soars 8.6%: is further upside left in the stock?
revance Therapeutics, Inc. (RVNC) was a big mover last session on higher-than-average trading volume. T...
January 23, 2023, 5:16 am
Carpe diem, daxxify: revance therapeutic preps for an exciting year
The global Botulinum Toxin market should reach $9.09 billion by 2029. Technically, revance Therapeutics...
January 19, 2023, 1:39 pm
revance therapeutics, inc. (rvnc) q3 2022 earnings call transcript
revance Therapeutics, Inc. (NASDAQ:RVNC ) Q3 2022 Results Conference Call November 8, 2022 4:30 PM ET C...
November 8, 2022, 10:26 pm
revance therapeutics, inc. (rvnc) ceo mark foley on q2 2022 results - earnings call transcript
revance Therapeutics, Inc. (NASDAQ:RVNC ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Co...
August 9, 2022, 11:20 pm